Clinical effect of oxytocin combined with ergotrine in the treatment of postpartum hemorrhage caused by uterine fatigue
Objective To explore the clinical effect of oxytocin combined with ergotrine in the treatment of postpartum hemorrhage caused by uterine fatigue.Methods 80 patients with postpartum hemorrhage due to uterine fatigue were selected and divided into control group(receiving oxytocin monotherapy)and study group(receiving oxytocin combined with ergotrine)according to different treatment methods,with 40 cases in each group.The amount of postpartum blood loss(2 h,24 h),hemostasis time,prenatal and postnatal 24 h hemoglobin level and clinical efficacy were compared between the two groups.Results The postpartum blood loss at 2 h and 24 h in the study group was significantly lower than that in the control group,and the difference was statistically significant(P<0.05).The time of hemostasis in the study group was shorter than that in the control group,the difference was statistically significant(P<0.05).There was no statistically significant difference in the prenatal hemoglobin level between the two groups(P>0.05),but the hemoglobin level at 24 h in the study group after treatment was higher than that in the control group,the difference was statistically significant(P<0.05).The total effective rate of the study group was higher than that of the control group,and the difference was statistically significant(P<0.05).Conclusion In the patients with postpartum hemorrhage due to uterine fatigue,the combination of oxytocin and ergotrine can significantly reduce the amount of bleeding,shorten the time of hemostasis,improve the hemostasis effect and improve the hemoglobin level of the patients.
OxytocinErgoxinePostpartum hemorrhage caused by uterine atonyHemoglobinClinical efficacyHemostatic time